Read now

CNS-ICNA 2020

Discover the conference highlights

Blood-based transcriptional risk scores and Alzheimer’s disease

Takeaway

  • Blood-based transcriptional risk score (TRS) is significantly associated with Alzheimer’s disease (AD) diagnosis and neuroimaging markers.

Why this matters

  • Transcriptional risk scores, a computation of polarized expressed levels of functional genes reflecting disease risk, have been proposed and utilized to distinguish Crohn’s disease patients from healthy controls; however, this approach has not been applied to AD.

  • Identification of early, and easily accessible AD markers has important implications for early disease diagnosis and development of targeted therapies in high risk individuals, given the increasing prevalence of AD worldwide.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.